The low molecular weight heparin dalteparin for prophylaxis and therapy of thrombosis in childhood: A report on 48 cases

European Journal of Pediatrics, Supplement

Volumn 158, Issue 3, 1999, Pages

  Nohe, N ^a   Flemmer, A ^a   Rumler R ^a   Praun, M ^a   Auberger, K ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Anti Xa activity; LMWH; Primary pulmonary hypertension; Thrombosis; Veno occlusive lung disease

Indexed keywords

ALTEPLASE; BLOOD CLOTTING FACTOR 10A; DALTEPARIN; LOW MOLECULAR WEIGHT HEPARIN; UROKINASE;

ADOLESCENT; ADULT; ARTERY THROMBOSIS; ARTICLE; BLEEDING; CHILD; CLINICAL ARTICLE; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EPISTAXIS; FEMALE; FIBRINOLYTIC THERAPY; HEPARINIZATION; HUMAN; INFANT; LUNG BIOPSY; LUNG VEIN OBSTRUCTION; MALE; NEWBORN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RECANALIZATION; THROMBOSIS PREVENTION; VEIN THROMBOSIS;

EID: 0033398401     PISSN: 09439676     EISSN: None     Source Type: Journal    
DOI: 10.1007/pl00014339     Document Type: Article

References (41)

1. Agnelli G, Borm J, Cosmi B, Levi M, tenCate JW (1988) Effects of standard heparin and a low molecular weight heparin (Kabi 2165) on fibrinolysis. Thromb Haemost 60(2):311-313.
2. Andrew M (1996) Indications and drugs for anticoagulation therapy in children. Thromb Res 81(2):61-73.
3. Andrew M, Ofusu F, Brooker L, Buchanan M (1989) The comparison of the pharmacokinetics of a low molecular heparin in the newborn and adult pig. Thromb Res 56:529-539.
4. Andrew M, Halton J, Massicotte MP (1995) Treatment of homozygous protein C deficiency in two children with low molecular weight heparin (LMWH) therapy. Thromb Haemost 73:939.
5. Arnesen H, Engebretsen LF, Ugland OM, Seljeflot J, Kierulf P (1987) Increased fibrinolytic activity after surgery induced by low dose heparin. Thromb Res 45:553-559.
6. Bratt G, Aberg W, Johansson M, Tornebohm E, Granqvist S, Lockner D (1990) Two daily subcutaneous injections of fragmin as compared with intravenous standard heparin in the treatment of deep venous thrombosis. Thromb Haemaost 64:506-512.
7. Broyer M, Gagnadoux MF, Sierro A, Fischer AM, Niaudet P (1991) Preventive treatment of vascular thrombosis after kidney transplantation in children with low molecular weight heparin. Transplantation Proceedings 23:1384-1385.
8. Bütikofer J, Vogt P, Knobluach M (1991) Pulmonale Venenverschlußkrankheit. Schweiz Med Wschr 121:1169-1175.
9. deVeber G, Chan A, Monagle P, Marzinotto V, Armstrong D, Massicotte P, Leaker M, Andrew M (1998) Anticoagulation therapy in pediatric patients with sinovenous thrombosis: a cohort study. Arch Neurol 55(12):1533-1537.
10. De Vries TW, Weening JJ, Roorda RJ (1991) Pulmonary venoocclusive disease: a case report and a review of therapeutic possibilities. Eur Respir J 4:1029-1032.
11. Dulitzki M, Pauzner R, Langewitz P (1994) Low molecular weight heparin during pregnancy. Int J Gynaecol Obstet 87:121-125.
12. Eriksson E, Wollter I.M, Christenson B, Stigendal L, Risberg B (1988) Heparin and fibrinolysis - comparison of subcutaneous administration of unfractionated and low molecular weight heparin. Thromb and Haemost 59(2):284-288.
13. Fijuvandraat K, Nurmohamed M, Peters M, Ploos van Amstel S, ten Cate J (1993) A cross-over dose finding study investigating a low molecular weight heparin (Fragmin R) in six children on chronic hemodialysis. Thromb Haemost 69(6):649.
14. FRISC study group (1996) Low molecular weight heparin during instability in coronary artery disease. Lancet 347 (9001):561-568.
15. Gaine SP, Rubin LJ (1998) Primary pulmonary hypertension. Lancet 352:719-725.
16. Geerts WH, Lay RM, Code KI (1996) A comparison of low dose heparin with low molecular weight heparin as prophylaxis against venous thromboembolism after major trauma. N Engl J Med 335:710-717.
17. Glick A, Kornowski R, Michowich (1996) Reduction of reinfarction and angina with use of low molecular weight heparin therapy after streptokinase (and heparin) in acute myocardial infarction. Am J Cardiol 77:145-148.
18. Green D, Hirsh J, Heit J, Prins M, Davidson A, Lensing WA (1994) Low molecular weight heparin: A critical analysis of clinical trials. Pharmacol Rev 46:89-109.
19. Gurfunkel EP, Manos EJ, Mejail RI (1995) Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia. J Amer Coll Cardiol 26:313-318.
20. Hiller E, Riess H, unter Mitarbeit von K. Auberger (1998) Thrombosen. In: Hiller E, Riess H (eds) Hämorrhagische Diathese und Thrombose. Wissenschaftliche Verlagsgesellschaft mbH Stuttgart, p 182.
21. Hirsh J, Levine MN (1992) Low molecular weight heparin. Blood 79:1-17.
22. Hull RD, Raskob GE, Pineo GF (1992) Subcutaneous low molecular weight heparin compared with continuous intravenous heparin in proximal deep-vein thrombosis. N Engl J Med 326:975-982.
23. Kay R, Wong KS, Yu Yl, Chan YW, Tsoi TH, Ahuja AT, Chan FL, Fong KY, Law CB, Wong A, Woo J (1995) Low-molecular-weight heparin for the treatment of acute ischemic stroke. N Engl J Med 333(24):1588-1593.
24. Leclerc JR, Geerts WH, Desjardins L (1992) Prevention of deep vein thrombosis after major knee surgery: a randomized double-blind trial comparing a low molecular weight heparin fragment (enoxaparin) to placebo. Thromb Haemost 67:417-423.
25. Leizorovicz A, Simmoneau G, Decousus H (1994) Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep vein thrombosis: a meta-analysis. BMJ 309:299-304.
26. Lensing AWA, Prins MH, Davidson BL, Hirsh J (1995) Treatment of deep venous thrombosis with low-molecular-weight heparins: a meta-analysis. Arch Intern Med 155:601-607.
27. Lopaciuk S, Meissner AJ, Filipecki S (1992) Subcutaneous low molecular weight heparin versus subcutaneous unfractionated heparin in the treatment of deep vein thrombosis: a Polish multicenter trial. Thromb Haemaost 68:14-18.
28. Massicotte P, Adams M, Marzinotto V, Brooker LA, Andrew M (1996) Low-molecular-weight heparin in pediatric patients with thrombotic disease: A dose finding study. J Pediatr 128 (3):313-318.
29. Neerstrand H, Östergaard P, Bergqvist D, Märtzsch T, Hedner U (1987) tPA inhibitor, tPA: AG, plasminogen and α2-antiplasmin after low molecular weight heparin or standard heparin. Fibrinolysis 1:39-43.
30. Nurmohamed MT, Rosendaal FR, Büller HR (1992) Low molecular weight heparin in general and orthopedic surgery: a meta-analysis. Lancet 349 (8812):152-156.
31. Pihusch R, Hiller E. Die Heparin-induzierte Thrombozytopenie. In: Niedermolekulare Heparine, Fragmin®. Joachim Schrader. Medikon Verlag München 1995, pp 133-138.
32. Piquet P, Laporte-Simitsidis S, Doubine S, Mismetti P, Houyel L, Decousus H (1995) Predictive enoxaparin (Lovenox) dosage regimens in neonates and children after cardiovascular surgery. Thromb Haemost 73:972.
33. Prandoni P, Lensing AWA, Büller HR (1992) Comparison of subcutaneous low-molecular-weight-heparin with intravenous standard heparin in proximal deep-vein thrombosis. Lancet 339:441-445.
34. Reach I, Thebaud HE, Dupuy CA, Kuntziger H, Debure A, Fievet P, Thoumazou G, de Groc F, Teboulle D, Combe S et al (1994) Optimization of enoxaparin dose in the prevention of coagulation in the circuits of hemodialysis: results of a multicenter study. Nephrologie 15(6):395-401.
35. Schrader J, Stibbe W, Armstrong VW, Kandt M, Muche R, Köstering H, Seidel D, Scheler F (1988) Comparison of low molecular weight heparin to standard heparin in hemodialysis/ hemofiltration. Kidney International 33:890-896.
36. Samama CM, Combe S, Ill P, Barre E, Dreux S, Viars P (1996) Are low molecular weight heparins useful for the prophylaxis and treatment of arterial thrombi ? Haemost 26 (Suppl 2):57-64.
37. Samama MM, Desnoyers PC, Conrad J, Bousser MG (1997) Acute ischemic stroke and heparin treatments. Thromb Haemost 78(1):172-179.
38. Schulman S, Grandqvist E, Lockner WB (1985) Thrombolysis and fibrinolytic parameters during heparin treatment of deep vein thrombosis. Thromb Res 39:607-612.
39. Simonneau G, Charbonnier B, Decousus H, Planchon B, Franco A, Ninet J, Sie P, Silsiguen M, Combe S (1993) Subcutaneous low molecular weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis. Arch Intern Med 153:1541-1546.
40. Sutor AH, Massicotte P, Leaker M, Andrew M (1997) Heparin Therapy in Pediatric Patients. Sem Thromb Hemost 23(3):303-319.
41. Van Biljon I, Van Damme-Lombaerts R, Demol A, Van Geet C, Proesmans W, Arnout J (1996) Low molecular weight heparin for anticoagulation during hemodialysis in children -a preliminary study. Eur J Pediatr 155 (1):70.